Company Profile

Synthomics Inc
Profile last edited on: 3/14/17      CAGE: 68XX8      UEI:

Business Identifier: Delivering Less Expensive, Higher Quality, Reduced Turn-Around-Time Oligonucleotide Synthesis Solutions
Year Founded
2013
First Award
2013
Latest Award
2015
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3477 Edison Way
Menlo Park, CA 94025
   (650) 549-8326
   info@synthomics.com
   www.synthomics.com
Location: Single
Congr. District: 18
County: San Mateo

Public Profile

Synthomics is organized around development and sale of reagents, and instrumentation that significantly improves upon key oligonucleotide synthesis needs for applications such as NGS, Gene Synthesis, Gene Editing, PCR, and DNA Data Storage. Delivering less expensive, higher quality, reduced turn-around-time Oligonucleotide Synthesis Solutions, the firm's r "Green Machine" instrument reduces the cost of DNA synthesis by a factor of 20X-100X, while at the same shortening turn-around-times, minimizing waste, and improving quality.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2015 2 NIH $1,133,000
Project Title: Instrumentation Enabling a 16-Fold Decrease in Oligonucleotide Cost

Key People / Management

  Keith Anderson -- Chief Executive Officer

  David Bullis -- Chief Business Development Officer

  Guillermo Cornejo -- VP of Engineering

  Jennifer Tomczyk